Related Experiment Video
Updated: May 11, 2026
06:32
Operating Procedures of the Electrochemotherapy for Treatment of Tumor in Dogs and Cats
Published on: October 24, 2016
Prognostic Factors for Injection-Site Sarcomas in Cats
1Veterinary Surgical Specialists, 21 East Mission Avenue, Spokane,WA 99202, USA. jharari103@aol.com
Compendium (Yardley, PA)
|May 25, 2013
Summary
This study reviewed feline injection-site sarcomas, finding that high-grade tumors (grade 3) correlated with metastasis and poorer survival. Tumor size was not a prognostic indicator in this cat cancer research.
Area of Science:
- Veterinary Oncology
- Comparative Pathology
Background:
- Injection-site sarcomas are aggressive tumors in cats.
- Understanding their clinical features and prognosis is crucial for treatment planning.
Purpose of the Study:
- To review the clinical features, treatment, and outcomes of injection-site sarcomas in cats.
- To identify prognostic factors for metastasis and survival.
Main Methods:
- Retrospective study of 57 feline cases from Italy and Switzerland.
- Inclusion of physical, laboratory, radiographic, and computed tomographic (CT) examinations.
- Analysis of treatment modalities including surgical excision, radiotherapy, and chemotherapy.
Main Results:
- Grade 3 tumors were associated with a higher likelihood of distant pulmonary metastases (21% of cases) and shorter survival.
- Median survival for survivors was 600 days; for non-survivors, it was 272 days.
- Tumor size and factors for local recurrence were not identified as prognostic indicators in this study.
Conclusions:
- Tumor grade is a significant prognostic factor for feline injection-site sarcomas.
- Further research is needed to identify factors influencing local recurrence and optimize treatment strategies.
- Advanced imaging aids in delineating tumor extent for surgical planning.
